https://preview.xbpnews.com/the-timken-company-tkr-receives-overweight-rating-from-jp-morgan-target-price-at-150 Stocks Telegraph en 2026-05-26 The Timken Company (TKR) Receives Overweight Rating from JP Morgan, Target Price at $150 https://preview.xbpnews.com/tectonic-therapeutic-inc-tecx-strong-buy-rating-indicates-significant-upside-potential Stocks Telegraph en 2026-05-26 Tectonic Therapeutic, Inc. (TECX): Strong Buy Rating Indicates Significant Upside Potential https://preview.xbpnews.com/occidental-petroleum-corporation-oxy-barclays-upgrades-to-overweight-with-price-target-of-72 Stocks Telegraph en 2026-05-26 Occidental Petroleum Corporation (OXY): Barclays Upgrades to Overweight with Price Target of $72 https://preview.xbpnews.com/marvell-technology-inc-mrvl-receives-buy-rating-from-hsbc-price-target-of-300 Stocks Telegraph en 2026-05-26 Marvell Technology, Inc. (MRVL) Receives ‘Buy’ Rating from HSBC, Price Target of $300 https://preview.xbpnews.com/cognex-corporation-cgnx-receives-overweight-rating-from-jp-morgan-with-price-target-of-75 Stocks Telegraph en 2026-05-26 Cognex Corporation (CGNX) Receives Overweight Rating from JP Morgan with Price Target of $75 https://preview.xbpnews.com/booz-allen-hamilton-holding-corporation-bah-analyst-rating-upgraded-to-buy-with-significant-upside-potential Stocks Telegraph en 2026-05-26 Booz Allen Hamilton Holding Corporation (BAH): Analyst Rating Upgraded to Buy with Significant Upside Potential https://preview.xbpnews.com/astrana-health-inc-asth-upgraded-to-overweight-strong-upside-potential-ahead Stocks Telegraph en 2026-05-26 Astrana Health, Inc. (ASTH) Upgraded to Overweight: Strong Upside Potential Ahead https://preview.xbpnews.com/allient-inc-alnt-upgrade-to-overweight-signals-optimism-price-target-set-at-80 Stocks Telegraph en 2026-05-26 Allient Inc. (ALNT) Upgrade to Overweight Signals Optimism; Price Target Set at $80 https://preview.xbpnews.com/agilon-health-inc-agl-barclays-analysts-shift-to-equal-weight-elevating-price-target-to-81 Stocks Telegraph en 2026-05-26 Agilon Health, Inc. (AGL): Barclays Analysts Shift to Equal-Weight, Elevating Price Target to $81 https://preview.xbpnews.com/lear-corporation-lea-td-cowen-upgrades-to-buy-with-target-price-of-165 Stocks Telegraph en 2026-05-26 Lear Corporation (LEA): TD Cowen Upgrades to Buy with Target Price of $165 https://preview.xbpnews.com/cosan-s-a-csan-downgraded-to-reduce-price-target-set-at-3-20 Stocks Telegraph en 2026-05-26 Cosan S.A. (CSAN) Downgraded to Reduce: Price Target Set at $3.20 https://preview.xbpnews.com/baycom-corp-bcml-secures-neutral-rating-with-analyst-price-target-indicating-upside-potential Stocks Telegraph en 2026-05-26 BayCom Corp (BCML) Secures Neutral Rating with Analyst Price Target Indicating Upside Potential https://preview.xbpnews.com/3-stocks-showing-consistent-activity-xbiotech-xbit-cue-biopharma-cue-cardiol-therapeutics-crdl Stocks Telegraph en 2026-05-26 3 Stocks Showing Consistent Activity: XBiotech (XBIT), Cue Biopharma (CUE), Cardiol Therapeutics (CRDL) https://preview.xbpnews.com/3-stocks-that-could-attract-attention-burning-rock-biotech-bnr-cardiol-therapeutics-crdl-dbv-technologies-dbvt Stocks Telegraph en 2026-05-26 3 Stocks That Could Attract Attention: Burning Rock Biotech (BNR), Cardiol Therapeutics (CRDL), DBV Technologies (DBVT) https://preview.xbpnews.com/3-stocks-that-could-gain-ground-cardiol-therapeutics-crdl-adlai-nortye-anl-neurogene-ngne Stocks Telegraph en 2026-05-26 3 Stocks That Could Gain Ground: Cardiol Therapeutics (CRDL), Adlai Nortye (ANL), Neurogene (NGNE)